Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

50978-11-5

Diatrizoic acid 2H2O

50978-11-5
18467-77-1

Dikegulac acid

18467-77-1
57-63-6

17alpha-ethynyl estradiol

57-63-6
53866-33-4

17beta-estradiol-2,4 D2

53866-33-4
114-07-8

Erythromycine

114-07-8
59319-72-1

Erythromycine A 2H2O

59319-72-1
57-91-0

Estradiol-17-alpha

57-91-0
50-28-2

Estradiol-17-beta

50-28-2
50-27-1

Estriol

50-27-1
53-16-7

Estrone

53-16-7
93106-60-6

Enrofloxacine

93106-60-6
123997-26-2

Eprinomectin

123997-26-2
24169-02-6

Econazole nitrate salt

24169-02-6
161796-84-5

Esomeprazole potassium salt

161796-84-5
668985-31-7

Esomeprazole magnesium hydrate

668985-31-7
299-42-3

Ephedrine

299-42-3
117091-64-2

Etoposide phosphate

117091-64-2
51-43-4

Epinephrine (-)

51-43-4
209253-82-7

Eplerenone 7-Carboxylic Acid

209253-82-7
379-79-3

Ergotamine tartrate

379-79-3